Description

In vivo therapeutic efficacy evaluation in a DSS-induced colitis mouse model, with body weight changes and disease activity index scores tracked over the treatment period.

Figure 5

Chart

Source Paper

"Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis …

Journal of nanobiotechnology (2023)

PMID: 37679849

DOI: 10.1186/s12951-023-01976-2

Cite This Figure

![Figure 5: In vivo therapeutic efficacy evaluation in a DSS-induced colitis mouse model, with body weight changes and disease activity index scores tracked over the treatment period.]()

> Source: Xiaoqin Han et al. ""Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast partic." *Journal of nanobiotechnology*, 2023. PMID: [37679849](https://pubmed.ncbi.nlm.nih.gov/37679849/)

<figure>
  <img src="" alt="In vivo therapeutic efficacy evaluation in a DSS-induced colitis mouse model, with body weight changes and disease activity index scores tracked over the treatment period." />
  <figcaption>Figure 5. In vivo therapeutic efficacy evaluation in a DSS-induced colitis mouse model, with body weight changes and disease activity index scores tracked over the treatment period.<br>  Source: Xiaoqin Han et al. ""Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast partic." <em>Journal of nanobiotechnology</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37679849/">37679849</a></figcaption>
</figure>

Related Evidence

Curcumin for Ulcerative Colitis (UC)

Grade B · 5 studies